First human tests begin for new drug in elderly volunteers
NCT ID NCT07219030
Summary
This is a very early study to see how a new drug called emraclidine moves through the body and how safe it is for healthy older adults to take. Researchers will give the drug to a small group of 32 elderly volunteers and closely monitor them for any side effects. The main goal is to gather basic information about the drug's safety and how the body processes it before testing it in people with specific illnesses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 276996
RECRUITINGGrayslake, Illinois, 60030, United States
Contact Phone: •••-•••-••••
-
Altasciences Clinical Los Angeles /ID# 276854
RECRUITINGCypress, California, 90630, United States
-
Clinical Pharmacology Of Miami /ID# 276856
RECRUITINGMiami, Florida, 33172, United States
Contact Phone: •••-•••-••••
-
K2 Medical Research, LLC /ID# 276636
RECRUITINGMaitland, Florida, 32751, United States
Conditions
Explore the condition pages connected to this study.